Tenax Therapeutics (TENX) Income Statement: Revenue & Earnings

Tenax Therapeutics Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Tenax Therapeutics, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.00	0.00	0.00	0.00	0.00
Cost of Revenue	0.00	0.00	0.00	0.00	0.00
Gross Profit	0.00	0.00	0.00	0.00	0.00
Operating Expenses
Research & Development	12.71	3.23	5.38	25.15	4.56
Selling, General & Administrative	6.79	5.01	5.68	7.58	5.31
Operating Expenses	19.49	8.23	11.05	32.73	9.87
Operating Income	-19.49	-8.23	-11.05	-32.73	-9.87
Other Income/Expense
Interest Income	1.91	0.48	0.00	0.00	0.00
Interest Expense	0.02	0.02	0.00	0.00	0.00
Other Income/Expense	0.00	0.06	0.01	0.25	0.03
Income
Income Before Tax	-17.60	-7.71	-11.05	-32.47	-9.85
Income Tax Expense	0.00	-0.03	0.00	0.00	0.00
Net Income	-17.60	-7.71	-11.05	-32.47	-9.85
Net Income - Continuous Operations	-17.60	-7.71	-11.05	-32.47	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-17.58	-7.68	-11.05	-32.36	-9.86
EBIT	-17.58	-7.69	-11.05	-32.47	-9.87
Depreciation & Amortization	0.00	0.01	0.01	0.11	0.00
Earnings Per Share
Basic EPS	-1.00	-31.00	-601.00	-2525.00	-
Diluted EPS	-1.00	-31.00	-601.00	-2525.00	-
Basic Shares Outstanding	15.27	0.25	0.02	0.01	0.00
Diluted Shares Outstanding	15.27	0.25	0.02	0.01	0.00